share_log

HC Wainwright & Co. Maintains Buy on Microbot Medical, Lowers Price Target to $8

HC Wainwright & Co. Maintains Buy on Microbot Medical, Lowers Price Target to $8

HC Wainwright & Co.維持對Microbot Medical的買入,將目標價下調至8美元
Benzinga ·  2023/05/09 05:37

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Microbot Medical (NASDAQ:MBOT) with a Buy and lowers the price target from $20 to $8.

HC Wainwright & Co. 分析師拉古拉姆·塞爾瓦拉朱維持Microbot Medical(納斯達克股票代碼:MBOT)的買入,並將目標股價從20美元下調至8美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論